Medical Xpress September 5, 2024
Rutgers University

A new study reveals that young patients treated with psychiatric medications receive potentially dangerous combinations with concerning frequency.

Researchers from Rutgers Health and other institutions recently analyzed New York State Medicaid records for more than 141,000 patients receiving any psychiatric medication. Nearly 400 of them had received at least one potentially dangerous combination for one month or longer. Doctors refer to these as severe drug-drug interactions, and their use is typically considered “contraindicated” (recommended against).

Senior study author Lawrence Kleinman, professor of pediatrics at Rutgers Robert Wood Johnson Medical School, cautioned that while some children whose illness is resistant to usual treatments may receive more benefit than the risk from the combination, “Good practice demands that patients and caregivers be...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Mental Health, Patient / Consumer, Provider, Survey / Study, Trends
Boosting chronic care management with mental health support | Viewpoint
1 in 5 Overdose Deaths in 2022 Had Unrelated Mental Illness
Charlie Health Partners with Cartwheel to Address the Student Mental Health Crisis
Mental Health Medication Trends: Antidepressants Up 21%, Opioids Down 17%
Podcast: Parental Stress New Focus for US Surgeon General

Share This Article